GlassScriptPhysician profile
Stephanie L Bissonnette
NPI 1164867792
$3,241.51
in general payments reported to CMS, 2019-2025
19 companies · $32.13 in 2025
The $32.13 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $489 · 2020: $113 · 2021: $314 · 2022: $679 · 2023: $1,615 · 2025: $32.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,240 · Food and Beverage: $407.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,239.97 |
| Food and Beverage | $407.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sage Therapeutics, LLC | $1,614.93 | 2023 | |
| Teva Pharmaceuticals USA, INC. | $327.60 | 2019-2022 | |
| Amneal Pharmaceuticals LLC | $282.87 | 2019-2022 | |
| Mdd US Operations, LLC | $182.88 | 2020-2022 | |
| Acorda Therapeutics, INC | $153.68 | 2019-2022 | |
| Allergan, INC. | $117.71 | 2019-2022 | |
| Boston Scientific Corporation | $104.46 | 2019-2020 | |
| Vertical Pharmaceuticals, LLC | $77.64 | 2019-2020 | |
| Abbvie INC. | $68.69 | 2022 | |
| Kyowa Kirin, INC. | $63.72 | 2021-2022 | |
| Abbott Laboratories | $56.31 | 2019 | |
| Adamas Pharmaceuticals, INC. | $46.95 | 2019 | |
| Medtronic, INC. | $32.13 | 2025 | Percept PC Brainsense |
| Ge Healthcare | $31.23 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $24.99 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $22.76 | 2022 | |
| Sunovion Pharmaceuticals INC. | $19.20 | 2021 | |
| Acadia Pharmaceuticals INC | $13.76 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Bissonnette listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.